Rosenblatt Maintains Buy on Viavi Solutions, Raises Price Target to $42

Benzinga Newsdesk www.benzinga.com Positive 82.8%

Neg 0% Neu 0% Pos 82.8%

Rosenblatt analyst Mike Genovese maintains Viavi Solutions (NASDAQ:VIAV) with a Buy and raises the price target from $27 to $42.